Creagri, Inc. Announces a Strategic Distribution Agreement for Olivenol® plus line of dietary supplements and skincare products.
HAYWARD-CA, 2/7/13-Creagri, Inc., and NewWave Biosciences, Inc., announced today that they have reached an agreement for the distribution of Olivenol® plus products across the therapeutic channel.
Initialized in Hayward, present the Chief executives and the executive team of the two companies, the agreement envisages the progressive introduction of the award winning Olivenol® plus line of organic products for health and wellness, featuring olive polyphenols and hydroxytyrosol, to health care professionals across the United States.“Starting today with Florida and rapidly expanding to the rest of the US, NewWave Bio will bring Olivenol® plus into the offices of rheumatologists, dermatologists, naturopaths, osteopaths and cardiologists allowing them to provide the opportunity to their patients to leverage the anti inflammatory power of HIDROX®—Olivenol’s® patented bioactive nutrient derived from the juice of organic olives—to obtain support and relief in conditions ranging from arthritis and osteoarthritis to psoriasis, eczema, contact dermatitis, and cardiovascular stress.” affirmed Roberto Crea, PhD, CEO and President of CreAgri.Internal Medicine specialist and Chief Medical Strategist for NewWave Biosciences, Dr. John Langdon has hailed Olivenol® plus as a breakthrough neutraceutical that bridges the science gap between countless commonly used nutritional supplements and mainstream well researched pharmaceutical products. “Olivenol’s® potent anti-inflammatory and antioxidant components have been subjected to both basic bench researches as well as peer reviewed clinical trials at respected medical centers and demonstrated major ability to prevent the inflammatory cascade at the root of the most common diseases afflicting virtually everyone at some point in their life.” affirms Dr. Langdon.“Today, New Wave Biosciences, Inc. is proud to exclusively license Olivenol® plus in North America and Canada. We considered many factors that solidified our interest to build a dedicated national sales force across America.” States, Brad Cole, President and Chief Executive Officer, New Wave Biosciences. “Our research considered solid bench marked studies, a world renowned Scientist in Roberto Crea, and the ability to help patients to manage severe skin conditions and chronic inflammation with a natural, organic, and cost effective option to supplement today’s therapies. Customer satisfaction is high with over 85% compliance over a three year period. We are ready to transform Olivenol® plus into a valuable household staple, and considering that olives have been around for thousands of years we are off to a great start.” Totally natural, organic, Halal, Kosher and GRAS, Olivenol® plus has been recognized with a Nutraceutical Business Technology Award (2011) for health care management --the highest recognition given to a Nutraceutical product—and the 2012 Paris Polyphenol Prize , for the most ecological and renewable method to obtain polyphenols from olive milling water. Assumed daily by tens of thousands of consumers across the planet, Olivenol® plus is celebrated as one of the most effective natural antioxidants available on the market today, and a safe answer to chronic ailments affecting millions worldwide.About NewWave: New Wave Biosciences, Inc. Winter Park, Florida, A leading national contracted sales force built with seasoned biopharmaceutical executives and sales representatives who are engaged in launching unique- innovative products and services to help patients and caregivers in the prevention of illness and disease. About CreAgri
CreAgri Inc., the inventor and developer of HIDROX® is the manufacturer of Olivenol plus. For further information, please visit www.creagri.com , www.olivenolplus.com , or contact Paolo Pontoniere, firstname.lastname@example.org.
- Contact Information
- Paolo Pontoniere
- VP Corporate Communications
- CreAgri, Inc.
- (1) 510-732-6478
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.